<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) are two debilitating health disorders afflicting millions worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Recent research has revealed similarities between AD and T2DM </plain></SENT>
<SENT sid="2" pm="."><plain>Both these protein conformational disorders are associated with <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:mp ids='MP_0001845'>inflammation</z:mp> and endoplasmic reticulum stress, en-route initiation and/or stage aggravation </plain></SENT>
<SENT sid="3" pm="."><plain>In this mini review we have tried to summarize studies describing <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> imbalance as common patho-mechanisms in T2DM and AD </plain></SENT>
<SENT sid="4" pm="."><plain>A reduction in tyrosine hydroxylase (TH) in the brain has been found to occur in <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>AD, T2DM and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> share common risk factors like <z:hpo ids='HP_0000716'>depression</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, whether TH is involved in the 'state of cognitive <z:hpo ids='HP_0000716'>depression</z:hpo>' that is the hallmark of AD and often accompanies <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and T2DM is also explored </plain></SENT>
</text></document>